Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

541.89
+60.4212.55%
Post-market: 542.000.1100+0.02%19:51 EDT
Volume:3.34M
Turnover:1.79B
Market Cap:23.24B
PE:19.39
High:557.37
Open:482.20
Low:475.46
Close:481.47
52wk High:609.35
52wk Low:409.07
Shares:42.89M
Float Shares:39.35M
Volume Ratio:6.52
T/O Rate:8.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.95
EPS(LYR):27.86
ROE:19.31%
ROA:11.61%
PB:3.63
PE(LYR):19.45

Loading ...

Earnings Flash (UTHR) United Therapeutics Posts Q2 EPS $7.27, vs. FactSet Est of $6.86

MT Newswires Live
·
Aug 05

United Therapeutics Q2 Revenue USD 783.3 Million Vs. IBES Estimate USD 805.6 Million

Reuters
·
Aug 05

United Therapeutics Q2 EPS $7.27 Beats $6.88 Estimate, Sales $783.300M Miss $805.645M Estimate

Benzinga Earnings
·
Aug 05

United Therapeutics Q2 EPS USD 7.27

THOMSON REUTERS
·
Aug 05

United Therapeutics Corporation Reports Second Quarter 2026 Financial Results

THOMSON REUTERS
·
Aug 05

United Therapeutics Chairperson, CEO Martine Rothblatt Reports Disposal of 9,500 Common Shares for $4.9 Million

Reuters
·
Aug 05

United Therapeutics CEO Martine Rothblatt Disposes of Common Shares Worth $4.96 Million

Reuters
·
Jul 30

United Therapeutics Says FDA Reviews Ralinepag NDA for Pulmonary Arterial Hypertension

Reuters
·
Jul 29

United Therapeutics Corp - Advance Outcomes Phase 3 Study of Ralinepag in Pah Meets Primary and Secondary Endpoints

THOMSON REUTERS
·
Jul 29

Earning Preview: United Therapeutics Q2 revenue is expected to increase by 0.17%, and institutional views are bullish

Earnings Agent
·
Jul 29

United Therapeutics CEO Martine Rothblatt Reports Sale of 9,500 Common Shares Worth $5.04 Million

Reuters
·
Jul 27

Did a High-Profile Board Addition and ESOP Moves Just Shift United Therapeutics' (UTHR) Investment Narrative?

Simply Wall St.
·
Jul 24

United Therapeutics Director Victor J. Dzau Files Initial Beneficial Ownership Statement

Reuters
·
Jul 24

United Therapeutics CEO Martine A. Rothblatt Disposes of 8,500 Common Shares Worth $4.53 Million

Reuters
·
Jul 24

United Therapeutics Corp - Appoints Victor Dzau to Board of Directors on July 22, 2026

THOMSON REUTERS
·
Jul 23

Press Release: United Therapeutics Corporation to Report Second Quarter 2026 Financial Results Before Market Open on Wednesday, August 5, 2026

Dow Jones
·
Jul 22

United Therapeutics Updates Financial Calendar Ahead of Quarterly Results Release, Webcast

Reuters
·
Jul 22

United Therapeutics Chairperson, CEO Martine Rothblatt Reports Sale of 9,500 Shares for $5.03 Million

Reuters
·
Jul 22

Julien Nono-Womdim’s Top Picks for July 21, 2026

Bloomberg
·
Jul 22

United Therapeutics Corp : Leerink Partners Cuts Target Price to $695 from $700

THOMSON REUTERS
·
Jul 21